newsfilter
← Latest News
GlobeNewswire·

Ryoncil® Sales Increase 60% in December Quarter to US$35.1M

NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ:MESO, ASX:MSB)), global leader in allogeneic cellular medicines for inflammatory diseases, today announced gross revenue of US$35.1 million on